All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

CCM Pharma offers 525bp-550bp on euro TLB

CCM Pharma, the new pharmaceutical company that private equity group Cinven is forming by merging two of its recent acquisitions, has set price talk on its new £160m-equivalent euro-denominated term loan ‘B’ at 525bp-550bp.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree